Search results
Mirum (MIRM) Rises More Than 30% in Past 3 Months: Here's Why
Zacks via Yahoo News· 2 weeks agoThe recent label expansion of Mirum's (MIRM) lead drug, Livmarli, is expected to drive sales in the...
Ironwood (IRWD) Q1 Earnings & Revenues Fall Shy of Estimates
Zacks via Yahoo News· 2 months agoIronwood (IRWD) incurs loss in the first quarter of 2024. Revenues decline year over year and miss...
Gilead (GILD) Q1 Loss Narrower Than Expected, Sales Beat
Zacks via Yahoo News· 3 months agoGilead Sciences, Inc. GILD reported better-than-expected results in the first quarter, as its loss...
Canadian parents advocate for organ donation as baby daughter with rare liver disease awaits...
Yahoo Canada Style· 3 months agoThis article is for informational purposes only and is not a substitute for professional medical...
Woman's constant itching turned out to be a sign of rare liver disease
Yahoo Life UK· 4 months agoFlo Moffat-Charles was diagnosed with incurable liver disease primary sclerosing cholangitis shortly...
Mirum's (MIRM) Q4 Earnings Lag Estimates, Revenues Beat
Zacks via Yahoo News· 5 months agoMirum Pharmaceuticals, Inc. MIRM reported a fourth-quarter 2023 loss of 66 cents per share, wider...
Biotech Stock Roundup: BIIB's Q4 Results, CBAY Up on GILD's Acquisition & Other Updates
Zacks via Yahoo News· 5 months agoIt has been a busy week for the biotech sector, with earnings results. Biogen BIIB reported...
Mirum (MIRM) Down on Failure of Mid-Stage Study on Livmarli
Zacks via Yahoo News· 7 months agoMirum (MIRM) faces a setback in its efforts to expand its lead drug Livmarli's label for the...
Tharimmune (THAR) Up on Positive Data From Pipeline Candidate
Zacks via Yahoo News· 8 months agoTharimmune (THAR) announces positive data from a phase I study on TH104 and the development timeline...